LOC283143 inhibitors constitute a specialized chemical class designed to selectively target and modulate the function of the non-coding RNA LOC283143. As part of the expansive family of non-coding RNAs, LOC283143 falls within the category of long intergenic non-protein coding RNAs (lincRNAs). Despite lacking the capacity to encode proteins, lincRNAs have emerged as pivotal regulators of diverse cellular processes. The inhibitors developed for LOC283143 are intricately designed to interact with the specific molecular structure of this non-coding RNA, aiming to disrupt its normal interactions within the cellular environment and potentially influence various cellular regulatory pathways.
The molecular architecture of LOC283143 inhibitors is meticulously crafted to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. This interaction holds the potential to impact the regulatory functions that LOC283143 may exert in cellular processes. In laboratory research, these inhibitors serve as indispensable tools, enabling scientists to probe the nuanced functions of LOC283143 in diverse cellular contexts. By manipulating the function of LOC283143, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC283143 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that incorporates into DNA and RNA, leading to demethylation and potentially altering gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, this compound inhibits DNA methyltransferase, potentially affecting transcription of lncRNAs. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor that could change the epigenetic state of the LINC00900 genomic locus, reducing its expression. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $180.00 $655.00 | 2 | |
Donor of methyl groups that might affect methylation patterns on DNA associated with LINC00900, influencing its transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Binds to GC-rich DNA sequences and interferes with transcription factor binding, possibly affecting lncRNA expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Known to inhibit transcription broadly, could reduce the expression of LINC00900 among other genes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can broadly affect protein synthesis and might indirectly impact lncRNA expression. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $110.00 $450.00 | 8 | |
Activates NQO1 and alters cellular redox states, which can influence signaling pathways and gene expression profiles. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that changes chromatin structure and can affect gene expression, including lncRNAs. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor with potential to modulate chromatin state and gene expression patterns. | ||||||